Rothschild Investment Corp Adaptive Biotechnologies Corp Transaction History
Rothschild Investment Corp
- $1.19 Billion
- Q3 2023
A detailed history of Rothschild Investment Corp transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Rothschild Investment Corp holds 10,000 shares of ADPT stock, worth $40,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$40,400% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding ADPT
# of Institutions
200Shares Held
146MCall Options Held
2.6KPut Options Held
143K-
Viking Global Investors LP30MShares$121 Million0.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$52 Million0.0% of portfolio
-
Matrix Capital Management Company, LP Waltham, MA11.6MShares$46.8 Million0.35% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$45.2 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.6MShares$42.7 Million0.24% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $577M
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...